OBJECTIVE	To assess the efficacy and safety of avocado/soybean unsaponifiables ( ASU ) in the treatment of patients with symptomatic osteoarthritis ( OA ) of the knee or hip , as well as the potential residual effects of ASU after stopping treatment , to determine whether ASU might be a symptomatic slow-acting drug for the treatment of OA .\